We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Dec 19
The new drug differs from many established acute migraine treatments by lowering blood pressure, rather than raising it
18 Nov 19
Repatha reduces the risk of myocardial infarction, stroke, and coronary revascularization in adults with established cardiovascular disease
Japanese scientists first sourced halichondrin from sea sponges in 1986, and have been attempting to manufacture it for…
13 Nov 19
The EMPULSE study is a multi-centre, randomised, double-blind study to assess the oral EMPagliflozin 10mg compared to placebo
11 Nov 19
Gazyva is a monoclonal antibody designed to attach to CD20, a protein that can be observed only on…
08 Nov 19
INXN-4001 makes use of non-viral delivery of a constitutively expressed multigenic plasmid to express human S100A1, SDF-1α, and…
08 Nov 19
Roxadustat is a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) indicated to promote erythropoiesis by increasing endogenous production of…
04 Nov 19
The results from EXCEED demonstrated a consistent and favourable safety profile for Cosentyx and no new safety signals…
30 Oct 19
The Phase III POSEIDON trial has reached a primary endpoint of statistically significant and clinically meaningful improvement in…
29 Oct 19
The clinical programme involves two studies, namely EAGLE-1, and EAGLE-2, and is conducted by the centres for disease…